Catalyst Pharmaceuticals, Inc. (CPRX)

NCM – Real Time Price. Currency in USD

31.14

-0.01 (-0.03%)

At close: May 12, 2026, 4:00 PM EDT

31.02

-0.12 (-0.39%)

After-hours: May 12, 2026, 7:47 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

589M

492M

398M

214M

Cost of goods sold

-125M

-106M

-85M

-34M

Gross Profit

464M

386M

314M

180M

Operating expenses (excl. COGS)

-206M

-190M

-227M

-78M

Operating Income

258M

195M

87M

102M

Non-operating income, total

26M

21M

Pretax income

284M

216M

95M

105M

Equity in earnings

Taxes

-69M

-52M

-23M

-22M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

214M

164M

71M

83M

Catalyst Pharmaceuticals, Inc. (CPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Catalyst Pharmaceuticals, Inc. (CPRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Catalyst Pharmaceuticals, Inc. (CPRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Catalyst Pharmaceuticals, Inc. (CPRX)

Income Statement (Annual)

Income Statement (Annual)